| 2025 | 2024 | ||
| Assets | Notes | $'000 | $'000 |
Investments | |||
| Financial investments | 9 | | |
| Deposits with ceding undertakings | | | |
| | | ||
Reinsurers' share of technical provisions | |||
| Provision for unearned premiums | 14 | | |
| Claims outstanding | 14 | | |
| | | ||
Debtors | |||
Debtors arising out of direct insurance operations | 10 | | |
Debtors arising out of reinsurance operations | 11 | | |
| Other debtors | 12 | | |
| | | ||
Other assets | |||
| Cash at bank and in hand | 18 | | |
| | | ||
Prepayments and accrued income | |||
| Deferred acquisition costs | 13 | | |
| Other prepayments and accrued income | | | |
| | | ||
| Total assets | | | |
Capital and reserves | |||
| Members' balances | | | |
| | | ||
Liabilities | |||
Technical provisions | |||
| Provision for unearned premiums | 14 | | |
| Claims outstanding | 14 | | |
| | | ||
Creditors | |||
Creditors arising out of direct insurance operations | 15 | | |
Creditors arising out of reinsurance operations | 16 | | |
Other creditors | 17 | | |
| | | ||
| Accruals and deferred income | | | |
| Total liabilities | | | |
| Total liabilities, capital and reserves | | |
| 2025 | 2024 | |
| $'000 | $'000 | |
Members’ balances brought forward at 1 January | | |
Total comprehensive income for the financial year | | |
Payments of profit to members' personal reserve funds | ( | ( |
Members’ balances carried forward at 31 December | | |
| 2025 | 2024 | ||
| Notes | $'000 | $'000 | |
Cash flows from operating activities | |||
Profit for the financial year | | | |
Adjustments for: | |||
(Decrease)/increase in gross technical provisions | 14 | ( | |
Decrease)/(increase) in reinsurers' share of gross technical provisions | 14 | | ( |
Decrease/(increase) in debtors | | ( | |
(Decrease) /increase in creditors | ( | | |
Movement in other assets/liabilities | | ( | |
| Investment return | 7 | ( | ( |
Foreign exchange | ( | | |
Net cash flows from operating activities | | | |
Cash flows from investing activities | |||
Purchase of equity and debt securities | ( | ( | |
Sale of equity and debt securities | | | |
Investment income received | | | |
Net cash flows from investing activities | ( | ( | |
Cash flows from financing activities | |||
Distribution of profit | ( | ( | |
Net cash flows from financing activities | ( | ( | |
Net (decrease)/increase in cash and cash equivalents | ( | | |
Cash and cash equivalents at the beginning of the year | | | |
Foreign exchange on cash and cash equivalents | | ( | |
| Cash and cash equivalents at the end of the year | 18 | | |
4 Net operating expenses | ||
| 2025 | 2024 | |
| $'000 | $'000 | |
Acquisition costs | | |
Change in deferred acquisition costs | | ( |
Administrative expenses | | |
Reinsurance commissions and profit participation | ( | ( |
| Net operating expenses | | |
| 2025 | 2024 | |
| $'000 | $'000 | |
Total commission for direct insurance business | | |
| 2025 | 2024 | |
| $’000 | $’000 | |
Fees payable to the syndicate’s auditor for the audit of these syndicate annual accounts | | |
Fees payable to the syndicate's auditor and its associates in respect of other services pursuant to legislation to align with Lloyds | | |
Total | 389 | 351 |
2025 | 2024 | |
| $’000 | $’000 | |
Directors' emoluments | | |
| 2025 | 2024 | |
| $’000 | $’000 | |
Emoluments | | |
Number of employees | ||
| 2025 | 2024 | |
| Administration and finance | | |
| Underwriting | | |
| Claims | | |
| Investments | | |
| Total | | |
| 2025 | 2024 | |
| $’000 | $’000 | |
| Wages and salaries | | |
| Social security | | |
| Other pension costs | | |
| Other | | |
| Total | | |
| 2025 | 2024 | |
| $’000 | $’000 | |
Interest and similar income | ||
From financial assets designated at fair value through profit or loss | ||
Interest and similar income | | |
From financial assets classified at amortised cost | ||
Interest on cash at bank | | |
Other income from investments | ||
From financial assets designated at fair value through profit or loss | ||
Gains on the realisation of investments | | |
Losses on the realisation of investments | ( | ( |
Unrealised gains on investments | | |
Unrealised losses on the investments | ( | ( |
Financial liabilities at amortised cost | ||
Interest expense | | |
Investment management expenses* | ( | ( |
Total investment return | | |
| Transferred to the technical account from the non technical account | | |
| 2025 | 2024 | |
| $’000 | $’000 | |
| Listed investments | | |
| 2025 | 2024 | |
| $’000 | $’000 | |
| Financial assets measured at fair value through profit or loss | | |
| Total financial investments | | |
| 2024 | Level 1 | Level 2 | Level 3 | Assets held at amortised cost | Total |
| $’000 | $’000 | $’000 | $’000 | $’000 | |
Shares and other variable yield securities and units in unit trusts | | | | | |
Debt securities and other fixed income securities | | | | | |
Participation in investment pools | | | | | |
Syndicate loans to central fund | | | | | |
Other investments | | | | | |
| Total financial investments | | | | | |
| Derivative financial liabilities | | | | | |
Total | | | | | |
| 2025 | 2024 | |
| $'000 | $'000 | |
| Due within one year | | |
| Due after one year | | |
Total | | |
| 2025 | 2024 | |
| $'000 | $'000 | |
| Due within one year | | |
| Due after one year | | |
Total | | |
| 2025 | 2024 | |
| $'000 | $'000 | |
Inter-syndicate balances | ||
Amounts due from Syndicate 623 | 4,933 | 4,384 |
Amounts due from Syndicate 2623 | — | 48,757 |
Total inter-syndicate balances | | |
| Other | | |
Total | | |
| 2025 | 2024 | |||||
| Gross | Reinsurance | Net | Gross | Reinsurance | Net | |
| $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | |
| Balance at 1 January | | ( | | | ( | |
Incurred deferred acquisition costs | | ( | | | ( | |
Amortised deferred acquisition costs | ( | | ( | ( | | ( |
| Foreign exchange movements | | | | ( | | ( |
| Balance at 31 December | | ( | | ( | |
Gross: | |||||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | |
Pure underwriting year | $ '000 | $ '000 | $ '000 | $ '000 | $ '000 | $ '000 | $ '000 | $ '000 | $ '000 | $ '000 | $ '000 |
Estimate of gross claims | |||||||||||
at end of underwriting year | | | | | | | | ||||
one year later | | | | ||||||||
two years later | | | | | |||||||
three years later | | | | ||||||||
four years later | | | |||||||||
five years later | | | |||||||||
six years later | | | |||||||||
seven years later | | ||||||||||
eight years later | |||||||||||
nine years later | |||||||||||
Estimate of gross claims reserve | | | | | | ||||||
Provision in respect of prior years | |||||||||||
Less gross claims paid | ( | ( | ( | ( | ( | ( | ( | | ( | ( | ( |
Gross claims reserves | | | | | | | | | | | |
| 2025 | 2024 | |
| $'000 | $'000 | |
| Due within one year | | |
| Due after one year | | |
Total | | |
| 2025 | 2024 | |
| $'000 | $'000 | |
| Due within one year | | |
| Due after one year | | |
Total | | |
| 2025 | 2024 | |
$'000 | $'000 | |
| Cash at bank and in hand* | | |
Short term debt instruments presented within other financial investments | | |
| Total cash and cash equivalents | | |
| 2025 | 2024 | |
| $'000 | $'000 | |
Short term debt instruments presented within other financial investments | | |
Total cash and cash equivalents not available for use by the syndicate | | |
| 2025 | 2024 | |||||
| Start of period | End of period | Average | Start of period | End of period | Average | |
| Sterling | | | | | | |
| Euro | | | | | | |
| US dollar | | | | | | |
Canadian dollar | | | | | | |
Australian dollar | | | | | | |